TITLE

Auspitz sign-off

AUTHOR(S)
Sabri, Ahmad Ayaz; Qayyum, Muhammad Ahad
PUB. DATE
April 2007
SOURCE
CMAJ: Canadian Medical Association Journal;4/10/2007, Vol. 176 Issue 8, p1129
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A response by the authors to a letter to the editor about their article "Psoriasis with Auspitz sign," in the 2006 issue is presented.
ACCESSION #
24577307

 

Related Articles

  • Treatment of Psoriasis. Buckley, Deirdre A.; Rogers, Sarah // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p258 

    A letter to the editor is presented in response to the article "Treatment of Psoriasis," by Greaves and Weinstein in the March 2, 1995 issue.

  • Treatment of Psoriasis. Wright, Richard A. // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p258 

    A letter to the editor is presented in response to the article "Treatment of Psoriasis," by Greaves and Weinstein in the March 2, 1995 issue.

  • Treatment of Psoriasis. Greaves, Malcolm W.; Weinstein, Gerald D. // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p258 

    A response by Greaves and Weinstein to several letters to the editor about their article "Treatment of Psoriasis," in the March 2, 1995 issue is presented.

  • IMMUNOPATHOLOGY OF PSORIASIS. Jablonska, Stefania; Beutner, Ernst H. // Journal of Investigative Dermatology;Oct83, Vol. 81 Issue 4, p381 

    Presents a letter to the editor on immunopathology of psoriasis, published in the 1983 issue of the "Journal of Investigative Dermatology."

  • REPLY. Weiss, Virginia C.; van den Broek, Hans; Barrett, Shari; West, Dannis P. // Journal of Investigative Dermatology;Oct83, Vol. 81 Issue 4, p381 

    Presents a reply from the editor on immunopathology of psoriasis, published in the 1983 issue of the "Journal of Investigative Dermatology."

  • Immune Thrombocytopenia Associated with Efalizumab Therapy for Psoriasis. Warkentin, Theodore E.; Kwon, Paul // Annals of Internal Medicine;11/15/2005, Vol. 143 Issue 10, p761 

    Presents a letter to the editor related to the efalizumab therapy for psoriasis.

  • Treatment of Plaque Psoriasis. Millard, Thomas P.; Birch, Katie E.; Young, Elspeth R. // New England Journal of Medicine;12/20/2001, Vol. 345 Issue 25, p1853 

    A letter to the editor is presented in response to the article "Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes," by C. N. Ellis and G. G. Krueger in the July 26, 2001 issue.

  • Treatment of Plaque Psoriasis. Haserick, John R. // New England Journal of Medicine;12/20/2001, Vol. 345 Issue 25, p1853 

    A letter to the editor is presented in response to the article "Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes," by C. N. Ellis and G. G. Krueger in the July 26, 2001 issue.

  • Treatment of Plaque Psoriasis. Hanauer, Lonnie // New England Journal of Medicine;12/20/2001, Vol. 345 Issue 25, p1853 

    A letter to the editor is presented in response to the article "Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes," by C. N. Ellis and G. G. Krueger in the July 26, 2001 issue.

  • Treatment of Plaque Psoriasis. Ellis, Charles N.; Krueger, Gerald G. // New England Journal of Medicine;12/20/2001, Vol. 345 Issue 25, p1853 

    A response by Charles N. Ellis and Gerald G. Krueger to letters to the editor about their article "Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes" in the July 26, 2001 issue is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics